Should we be targeting triglyceride as well as LDL cholesterol in the battle against coronary heart disease?

被引：0
|
作者：
Gaw, Allan [1 ]
机构：
[1] Univ Glasgow, Western Infirm, Glasgow Clin Res Facil, Glasgow G11 6NT, Lanark, Scotland
来源：
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2008年 / 5卷 / 08期
关键词：
acute coronary syndrome; coronary heart disease; LDL cholesterol; statin; triglyceride;
D O I：
10.1038/ncpcardio1249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：438 / 439
页数：2
相关论文
共 50 条
  • [41] Serum cholesterol and coronary heart disease - A public health perspective
    Verschuren, WMM
    NETHERLANDS JOURNAL OF MEDICINE, 1997, 51 (01): : 1 - 9
  • [42] DIET, BLOOD CHOLESTEROL LEVELS, AND CORONARY HEART-DISEASE
    STONE, NJ
    CORONARY ARTERY DISEASE, 1993, 4 (10) : 871 - 881
  • [43] The role of cholesterol reduction in secondary prevention of coronary heart disease
    Hanke, H
    Höher, M
    MEDIZINISCHE WELT, 1999, 50 (4-5): : 153 - 159
  • [44] The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease
    Ho K.-T.
    Chin K.-W.
    Ng K.-S.
    Alemao E.
    Rajagopalan S.
    Yin D.
    American Journal of Cardiovascular Drugs, 2006, 6 (6) : 383 - 391
  • [45] THE HELP-LDL-APHERESIS MULTICENTER STUDY, AN ANGIOGRAPHICALLY ASSESSED TRIAL ON THE ROLE OF LDL-APHERESIS IN THE SECONDARY PREVENTION OF CORONARY HEART-DISEASE .2. FINAL EVALUATION OF THE EFFECT OF REGULAR TREATMENT ON LDL-CHOLESTEROL PLASMA-CONCENTRATIONS AND THE COURSE OF CORONARY HEART-DISEASE
    SCHUFFWERNER, P
    GOHLKE, H
    BARTMANN, U
    BAGGIO, G
    CORTI, MC
    DINSENBACHER, A
    EISENHAUER, T
    GRUTZMACHER, P
    KELLER, C
    KETTNER, U
    KLEOPHAS, W
    KOSTER, W
    OLBRICHT, CJ
    RICHTER, WO
    SEIDEL, D
    SCHOPPENTHAU, M
    SCHLIERF, G
    MARBURGER, C
    ZOLLNER, N
    SUHLER, K
    SCHWANDT, P
    SCHOTTENFELDNAOR, J
    LESCHKE, M
    GRIES, FA
    GOHLKE, W
    BESTEHORN, HP
    BRAUNAGEL, K
    BAUER, M
    HORL, WH
    JUST, H
    MEINERTZ, T
    SCHOLLMEYER, P
    WIELAND, H
    PREVIATO, L
    CREPALDI, G
    ARMSTRONG, VW
    SCHOEPPE, W
    MUCHE, R
    REXER, H
    HILGERS, R
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (11) : 724 - 732
  • [46] The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary microvascular disease
    Liao, Li Ping
    Wu, Lei
    Yang, Yang
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [47] Lipoprotein(a) and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Should We Also Blame the LDL Receptor?
    Santos, Raul D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (19) : 1990 - 1991
  • [48] Coronary heart disease in children with familial hypercholesterolemia: Maximum therapy with LDL apheresis
    Mellwig, KP
    Schmidt, HK
    Brettschneider-Meyer, A
    Meyer, H
    Jaeger, BR
    Walli, AK
    Seidal, D
    Horstkotte, D
    INTERNIST, 2003, 44 (04): : 476 - 480
  • [49] Platelet-inspired targeting delivery for coronary heart disease
    Jiang, Yu
    Wei, Zhi-Yao
    Song, Zhi-Feng
    Qian, Hai-Yan
    HELIYON, 2024, 10 (05)
  • [50] Autoantibodies Against Lipoprotein(a) in Patients With Coronary Heart Disease
    Afanaseva, O. I.
    Klesareva, E. A.
    Levashov, P. A.
    Berestetskaya, Yu. V.
    Ezhov, M. V.
    Artemeva, N. V.
    Pokrovskiy, S. N.
    KARDIOLOGIYA, 2014, 54 (06) : 4 - 8
12345